MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Начало・Списък с акции・Pulse Biosciences Inc

Pulse Biosciences Inc

Затворен

СекторЗдравеопазване

17.11 -2.23

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.76

Максимум

17.88

Ключови измерители
By Trading Economics
Приходи	-2.4M -19M
EPS	-0.28
Марж на печалбата	-2,018.63
Служители	75
EBITDA	-857K -19M

Дивиденти
By Dow Jones
Следващи печалби	29.10.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	308M 1.3B
Предишно отваряне	19.34
Предишно затваряне	17.11

Настроения в новините

By Acuity

50%

172 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

16.59 / 17.17 Подкрепа & съпротива

Pulse Biosciences Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.10.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13.10.2025 г., 21:07 ч. UTC

Придобивния, сливания и поглъщания

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13.10.2025 г., 17:03 ч. UTC

Значими двигатели на пазара

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13.10.2025 г., 23:53 ч. UTC

Пазарно говорене

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13.10.2025 г., 23:39 ч. UTC

Пазарно говорене

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13.10.2025 г., 22:15 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

13.10.2025 г., 22:15 ч. UTC

Пазарно говорене

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13.10.2025 г., 21:57 ч. UTC

Придобивния, сливания и поглъщания

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13.10.2025 г., 21:36 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

13.10.2025 г., 21:36 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

13.10.2025 г., 21:36 ч. UTC

Пазарно говорене

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13.10.2025 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13.10.2025 г., 21:06 ч. UTC

Придобивния, сливания и поглъщания

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13.10.2025 г., 20:52 ч. UTC

Придобивния, сливания и поглъщания

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

13.10.2025 г., 20:35 ч. UTC

Придобивния, сливания и поглъщания

Goldman Expects to Close Deal in 1Q

13.10.2025 г., 20:34 ч. UTC

Придобивния, сливания и поглъщания

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13.10.2025 г., 20:33 ч. UTC

Придобивния, сливания и поглъщания

Industry Ventures Currently Manages $7B of Assets Under Supervision

13.10.2025 г., 20:32 ч. UTC

Придобивния, сливания и поглъщания

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13.10.2025 г., 20:31 ч. UTC

Придобивния, сливания и поглъщания

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13.10.2025 г., 20:29 ч. UTC

Придобивния, сливания и поглъщания

Goldman Sachs to Buy VC Firm Industry Ventures

13.10.2025 г., 19:05 ч. UTC

Пазарно говорене

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13.10.2025 г., 18:59 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13.10.2025 г., 18:26 ч. UTC

Пазарно говорене

Precious Metals Close at New Record Highs -- Market Talk

13.10.2025 г., 18:10 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

13.10.2025 г., 18:10 ч. UTC

Пазарно говорене

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13.10.2025 г., 17:05 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

13.10.2025 г., 17:05 ч. UTC

Пазарно говорене

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13.10.2025 г., 16:03 ч. UTC

Придобивния, сливания и поглъщания

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13.10.2025 г., 15:35 ч. UTC

Пазарно говорене

Precious Metals Push Record Highs Further -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Pulse Biosciences Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Pulse Biosciences Inc през последните 3 месеца.

Техническа оценка

By Trading Central

16.59 / 17.17Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Настроение

By Acuity

172 / 371 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.